Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double

The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois.Danish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last year due to the blockbuster success of its weight loss drugs, on Thursday beat profit estimates for the first quarter.Net profit rose 28% year-on-year to 25.4 billion Danish kroner ($3.65 billion), versus analyst expectations of 23.7 billion kroner, according to LSEG data.Sales of popular ...